Literature DB >> 32710548

Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?

Matteo Megna1, Gabriella Fabbrocini1, Claudio Marasca1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32710548     DOI： 10.1111/ijd.15059

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN： 0011-9059            Impact factor:   2.736


× No keyword cloud information.
  2 in total

1.  Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".

Authors:  Luca Potestio; Elisa Camela; Gabriella Fabbrocini; Matteo Megna
Journal:  J Cosmet Dermatol       Date:  2021-10-28       Impact factor: 2.696

2.  Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610."

Authors:  Luca Potestio; Elisa Camela; Andrea Tajani; Gabriella Fabbrocini; Matteo Megna
Journal:  J Cosmet Dermatol       Date:  2022-01-27       Impact factor: 2.189
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.